Detailed information for compound 418206

Basic information

Technical information
  • TDR Targets ID: 418206
  • Name: 2-[3-(1-benzofuran-2-yl)phenyl]-6-morpholin-4 -ylthiopyran-4-one
  • MW: 389.467 | Formula: C23H19NO3S
  • H donors: 0 H acceptors: 1 LogP: 4.33 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=c1cc(sc(c1)c1cccc(c1)c1cc2c(o1)cccc2)N1CCOCC1
  • InChi: 1S/C23H19NO3S/c25-19-14-22(28-23(15-19)24-8-10-26-11-9-24)18-6-3-5-16(12-18)21-13-17-4-1-2-7-20(17)27-21/h1-7,12-15H,8-11H2
  • InChiKey: FGZCCRKEIAJGKT-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[3-(benzofuran-2-yl)phenyl]-6-morpholino-thiopyran-4-one
  • 2-[3-(2-benzofuranyl)phenyl]-6-morpholino-4-thiopyranone
  • 2-[3-(1-benzofuran-2-yl)phenyl]-6-morpholin-4-yl-thiopyran-4-one

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0616 0.156 0.156
Loa Loa (eye worm) hypothetical protein 0.0616 0.156 0.156
Schistosoma mansoni subfamily M12A unassigned peptidase (M12 family) 0.0616 0.156 0.156
Echinococcus multilocularis Tolloid protein 1 0.0616 0.156 1
Plasmodium falciparum cysteine repeat modular protein 1 0.0473 0 0.5
Plasmodium vivax cysteine repeat modular protein 1, putative 0.0473 0 0.5
Toxoplasma gondii calcium binding egf domain-containing protein 0.0616 0.156 0.2875
Trypanosoma cruzi hypothetical protein, conserved 0.0473 0 0.5
Brugia malayi Calcium binding EGF domain containing protein 0.0616 0.156 0.156
Loa Loa (eye worm) multiple epidermal growth factor-like domains 6 0.0616 0.156 0.156
Onchocerca volvulus Arrow homolog 0.0616 0.156 0.156
Brugia malayi Low-density lipoprotein receptor repeat class B containing protein 0.0616 0.156 0.156
Loa Loa (eye worm) hypothetical protein 0.1391 1 1
Toxoplasma gondii PAN domain-containing protein 0.0971 0.5426 1
Toxoplasma gondii PAN domain-containing protein 0.0971 0.5426 1
Onchocerca volvulus 0.1391 1 1
Loa Loa (eye worm) bone morphogenetic protein 1b 0.0616 0.156 0.156
Echinococcus multilocularis fibrillin 1 0.0616 0.156 1
Loa Loa (eye worm) hypothetical protein 0.0616 0.156 0.156
Toxoplasma gondii calcium binding egf domain-containing protein 0.0616 0.156 0.2875
Loa Loa (eye worm) hypothetical protein 0.0616 0.156 0.156
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.1391 1 1
Loa Loa (eye worm) hypothetical protein 0.0649 0.192 0.192
Onchocerca volvulus 0.109 0.673 0.673
Leishmania major hypothetical protein, conserved 0.0473 0 0.5
Brugia malayi Fibulin-1 precursor 0.0616 0.156 0.156
Echinococcus multilocularis laminin 0.0616 0.156 1
Loa Loa (eye worm) low-density lipoprotein receptor repeat class B containing protein 0.0616 0.156 0.156
Echinococcus granulosus Tolloid protein 1 0.0616 0.156 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.1391 1 1
Loa Loa (eye worm) hypothetical protein 0.1391 1 1
Echinococcus granulosus laminin 0.0616 0.156 1
Schistosoma mansoni egf-like domain protein 0.0616 0.156 0.156

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) 0 Inhibition of DNA-PK in HeLa cell nuclear extracts ChEMBL. 17371003

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.